Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Fengcai ZhuNHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China. Electronic address: [email protected]Yu-Hua LiChina National Institute for Food and Drug Control, Beijing, ChinaXu-Hua GuanHubei Provincial Center for Disease Control and Prevention, Wuhan, ChinaLi-Hua HouWen-Juan WangClinical Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: [email protected]Jingxin LiNHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, ChinaShi-Po WuBusen WangZhao WangHubei Provincial Center for Disease Control and Prevention, Wuhan, ChinaLei WangChina National Institute for Food and Drug Control, Beijing, ChinaSi-Yue JiaNHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, ChinaHu-Dachuan JiangNHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, ChinaLing WangChina National Institute for Food and Drug Control, Beijing, ChinaTao JiangBeijing Institute of Microbiology and Epidemiology, State Key Laboratory of Pathogen and Biosecurity, Beijing, ChinaYi HuBeijing Institute of Microbiology and Epidemiology, State Key Laboratory of Pathogen and Biosecurity, Beijing, ChinaJin-Bo GouCanSino Biologics, Tianjin, ChinaSha-Bei XuClinical Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaJunjie XuXue-Wen WangWei WangClinical Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: [email protected]Wei ChenBeijing Institute of Biotechnology, Beijing, China. Electronic address: [email protected]
2020en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0